Effects of gabapentin enacarbil on restless legs syndrome and leg pain in dementia with Lewy bodies

Psychogeriatrics

Volumn 14, Issue 2, 2014, Pages 132-134

  Fujishiro, Hiroshige ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

DLB; Dopaminergic agonist; Parkinson's disease; Psychiatric symptoms; Visual hallucinations

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; DONEPEZIL; GABAPENTIN ENACARBIL; PRAMIPEXOLE; RAMELTEON;

ADD ON THERAPY; AGED; AMNESIA; ANOSMIA; ARTICLE; BRAIN ATROPHY; CASE REPORT; CONSTIPATION; DIFFUSE LEWY BODY DISEASE; DRUG DOSE INCREASE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HUMAN; LEG PAIN; LOW DRUG DOSE; MEDICAL HISTORY; METAMORPHOSIS; MINI MENTAL STATE EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; RESTLESS LEGS SYNDROME; SIDE EFFECT; SLEEP DISORDER; TREATMENT RESPONSE; UNIFIED PARKINSON DISEASE RATING SCALE; VISUAL HALLUCINATION;

DLB; DOPAMINERGIC AGONIST; PARKINSON'S DISEASE; PSYCHIATRIC SYMPTOMS; VISUAL HALLUCINATIONS;

AGED; CARBAMATES; DOPAMINE AGONISTS; FEMALE; GAMMA-AMINOBUTYRIC ACID; HALLUCINATIONS; HUMANS; JAPAN; LEG; LEWY BODY DISEASE; MAGNETIC RESONANCE IMAGING; PAIN; RESTLESS LEGS SYNDROME; TREATMENT OUTCOME;

EID: 84904760984     PISSN: 13463500     EISSN: 14798301     Source Type: Journal    
DOI: 10.1111/psyg.12043     Document Type: Article

References (19)

1. Garcia-Borreguero D, Egatz R, Winkelmann J, Berger K. Epidemiology of restless legs syndrome: the current status. Sleep Med Rev 2006; 10: 153-167.
2. Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisir J. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 2003; 4: 101-119.
3. McKeith IG, Dickson DW, Lowe J etal. Consortium on DLB. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 2005; 65: 1863-1872.
4. Aurora RN, Kristo DA, Bista SR etal. The treatment of restless legs syndrome and periodic limb movement disorder in adults-an update for 2012: practice parameters with an evidence-based systematic review and meta-analyses: an American Academy of Sleep Medicine Clinical Practice Guideline. Sleep 2012; 35: 1039-1062.
5. Goldman JG, Goetz CG, Brandabur M, Sanfilippo M, Stebbins GT. Effects of dopaminergic medications on psychosis and motor function in dementia with Lewy bodies. Mov Disord 2008; 23: 2248-2250.
6. Chiba Y, Fujishiro H, Iseki E etal. Retrospective survey of prodromal symptoms in dementia with Lewy bodies: comparison with Alzheimer's disease. Dement Geriatr Cogn Disord 2012; 33: 273-281.
7. Boeve BF. REM sleep behavior disorder: updated review of the core features, the RBD-neurodegenerative disease association, evolving concepts, controversies, and future directions. Ann N Y Acad Sci 2010; 1184: 15-54.
8. Fujishiro H. Treatment of visual hallucinations with ramelteon in dementia Lewy bodies. Nihon Ronen Igakkai Zasshi 2012; 49: 622-626.
9. Walters AS, LeBrocq C, Dhar A etal. Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med 2003; 4: 121-132.
10. Silber MH, Ehrenberg BL, Allen RP etal. An algorithm for the management of restless legs syndrome. Mayo Clin Proc 2004; 79: 916-922.
11. Ford B. Pain in Parkinson's disease. Mov Disord 2010; 25: 98-103.
12. Halliday GM, McCann H. The progression of pathology in Parkinson's disease. Ann N Y Acad Sci 2010; 16: 653-661.
13. Fujishiro H, Iseki E, Higashi S etal. Distribution of cerebral amyloid deposition and its relevance to clinical phenotype in Lewy body dementia. Neurosci Lett 2010; 486: 19-23.
14. Juri C, Rodriguez-Oroz M, Obeso JA. The pathophysiological basis of sensory disturbances in Parkinson's disease. J Neurol Sci 2010; 289: 60-65.
15. von Spiczak S, Whone AL, Hammers A etal. The role of opioids in restless legs syndrome: an [11C]diprenorphine PET study. Brain 2005; 128: 906-917.
16. Bentley AJ, Rosman KD, Mitchell D. Can the sensory symptoms of restless legs syndrome be assessed using a qualitative pain questionnaire? Clin J Pain 2007; 23: 62-66.
17. Karroum EG, Golmard JL, Leu-Semenescu S, Arnulf I. Sensations in restless legs syndrome. Sleep Med 2012; 13: 402-408.
18. Partinen M, Hirvonen K, Jama L etal. Open-label study of the long-term efficacy and safety of pramipexole in patients with Restless Legs Syndrome (extension of the PRELUDE study). Sleep Med 2008; 9: 537-541.
19. Hornyak M, Sohr M, Busse M. Evaluation of painful sensory symptoms in restless legs syndrome: experience from two clinical trials. Sleep Med 2011; 12: 186-189.